Literature DB >> 1459833

Calcium blockers enhance cisplatin-induced nephrotoxicity in rats.

J Uozumi1, T Ueda, T Yasumasu, Y Koikawa, J Kumazawa.   

Abstract

To examine the effects of calcium blockers on nephrotoxicity caused by cisplatin, the renal function and renal accumulation of Pt in Sprague-Dawley rats given 6.5 mg/kg i.v. cisplatin simultaneously with several doses of verapamil or nicardipine were evaluated. BUN, serum creatinine and kidney Pt concentrations in rats given more than 5.0 mg/kg of verapamil were significantly higher than those of the control animals injected with 6.5 mg/kg i.v. cisplatin alone, and the increase of each value was dependent upon the dose of verapamil. BUN, creatinine and kidney Pt in rats injected with more than 0.5 mg/kg i.p. nicardipine were also significantly higher than those of the controls. Calcium blockers enhanced the renal accumulation of Pt and the nephrotoxicity of cisplatin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459833     DOI: 10.1007/bf02550124

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  10 in total

1.  Modified reagents for determination of urea and ammonia.

Authors:  A L CHANEY; E P MARBACH
Journal:  Clin Chem       Date:  1962-04       Impact factor: 8.327

2.  The influence of verapamil on renal function in patients treated with cisplatin.

Authors:  J J Offerman; S Meijer; D T Sleijfer; N H Mulder; A J Donker; H Schraffordt Koops; G K van der Hem
Journal:  Clin Nephrol       Date:  1985-11       Impact factor: 0.975

3.  Determination of serum creatinine by a direct colorimetric method.

Authors:  D Heinegård; G Tiderström
Journal:  Clin Chim Acta       Date:  1973-02-12       Impact factor: 3.786

4.  Reduction of the renal toxicity of cis-dichlorodiammineplatinum(II) by probenecid.

Authors:  D A Ross; G R Gale
Journal:  Cancer Treat Rep       Date:  1979-05

5.  The protective potential of the combination of verapamil and cimetidine on cisplatin-induced nephrotoxicity in man.

Authors:  D T Sleijfer; J J Offerman; N H Mulder; M Verweij; G K van der Hem; H S Schraffordt Koops; S Meijer
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

6.  Systemic chemotherapy in tumor-bearing rats using high-dose cis-diamminedichloroplatinum(II) with low nephrotoxicity in combination with angiotensin II and sodium thiosulfate.

Authors:  H Kobayashi; K Hasuda; K Aoki; S Taniguchi; T Baba
Journal:  Int J Cancer       Date:  1990-05-15       Impact factor: 7.396

7.  The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.

Authors:  P T Daley-Yates; D C McBrien
Journal:  Biochem Pharmacol       Date:  1982-07-01       Impact factor: 5.858

8.  Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid.

Authors:  C Jacobs; C N Coleman; L Rich; K Hirst; M W Weiner
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

9.  Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis.

Authors:  G A Frick; R Ballentine; C W Driever; W G Kramer
Journal:  Cancer Treat Rep       Date:  1979-01

10.  Stimulatory action of verapamil on transport of organic acids in rat kidney cortical slices.

Authors:  Y Matsushima; M Gemba
Journal:  J Pharmacol Exp Ther       Date:  1982-08       Impact factor: 4.030

  10 in total
  3 in total

Review 1.  Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review.

Authors:  V Pinzani; F Bressolle; I J Haug; M Galtier; J P Blayac; P Balmès
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Analysis of Risk Factors for High-dose Cisplatin-induced Renal Impairment in Head and Neck Cancer Patients.

Authors:  Hiroyoshi Koide; Satoshi Noda; Yumi Okunuki; Shigehiro Owaki; Takeshi Shimizu; Tomohiro Terada; Shin-Ya Morita
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

3.  Antihypertensive Drug Combinations Modify Cisplatin-induced Acute Kidney Injury.

Authors:  Koji Takeuchi; Rintaro Sogawa; Satoko Tsuruhashi; Chika Motooka; Sakiko Kimura; Chisato Shimanoe
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.